or Try an Advanced Search...

    Pharmaceuticals Segment Stocks List

    Symbol Grade Name % Change
    XPH D SPDR S&P Pharmaceuticals ETF 1.14
    NVO B Novo Nordisk A/S -4.02
    PRGO A Perrigo Company 0.49
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Diabetes Diabetes Care Hormones Pharmaceutical Products Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Cough Dietary Supplement ETF Endocrine System Exchange Traded Fund Feminine Hygiene Gastrointestinal Generic Drug Glucagon Like Peptide 1 Growth Hormone

    Related ETFs - A few ETFs which own one or more of the above listed Pharmaceuticals Segment stocks.

    Symbol Grade Name Weight
    EDEN A iShares MSCI Denmark Capped ETF 23.21
    PPH B Market Vectors Pharmaceutical ETF 10.46
    IGTR C Innovator Gradient Tactical Rotation Strategy ETF 8.1
    PJIO D PGIM Jennison International Opportunities ETF 7.68
    AADR A WCM BNY Mellon Focused Growth ADR ETF 6.56
    View all Pharmaceuticals Segment ETFs...
    Compare ETFs
    Compare EDEN to AADR Compare EDEN to IGTR Compare EDEN to PJIO

        Pharmaceuticals Segment Stocks Recent News

        Date Stock Title
        May 2 NVO Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
        May 2 NVO Novo Nordisk slides while Moderna pops: Tale of two pharma stocks
        May 2 NVO Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK
        May 2 NVO Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
        May 2 NVO Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
        May 2 NVO Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
        May 2 NVO Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation
        May 2 NVO Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript
        May 2 NVO Top Midday Stories: Novo Nordisk, Linde Shares Fall Post-Earnings; Peloton Shares Plummet After Announcing Job Cuts, CEO Change; Exxon-Pioneer Deal Gets FTC Approval With One Caveat
        May 2 NVO Novo Nordisk Stock Falls After Pricing Pressure Mounts for Wegovy
        May 2 NVO Novo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast
        May 2 NVO GLP-1 drug prices falling at UK pharmacies, clinics: report
        May 2 NVO Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
        May 2 NVO Novo Nordisk says prices dropping for Wegovy, Ozempic: report
        May 2 NVO Novo Nordisk Lifts Full-Year Sales Outlook as Obesity, Diabetes Drugs Drive First-Quarter Topline Beat
        May 2 NVO UPDATE 1-Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1
        May 2 NVO Apple earnings on tap, investors digest Fed decision: Yahoo Finance
        May 2 NVO Why Markets Must Beware Powell’s Comments on Fed Rate Hikes, and 5 Other Things to Know Today
        May 2 NVO Growing demand for weight loss treatments drives sales at drugmaker Novo Nordisk
        May 2 NVO Novo Nordisk Hikes Guidance as Weight-Loss Drug Sales Surge. Why the Stock’s Falling.
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Diabetes Diabetes Care Hormones Pharmaceutical Products Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Cough Dietary Supplement ETF Endocrine System Exchange Traded Fund Feminine Hygiene Gastrointestinal Generic Drug Glucagon Like Peptide 1 Growth Hormone
        Pharmaceuticals Segment

        Pharmaceuticals segment is a sector of the healthcare industry that focuses on the research, development, production, and marketing of drugs and other pharmaceutical products. This segment includes companies that manufacture and distribute prescription and over-the-counter drugs, as well as those that provide related services such as contract manufacturing and clinical research.

        Browse All Tags